Welcome to LookChem.com Sign In|Join Free

CAS

  • or

769957-04-2

HDS02-174 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

769957-04-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 769957-04-2 Structure

  • Basic information

    1. Product Name: HDS02-174
    2. Synonyms: HDS02-174
    3. CAS NO:769957-04-2
    4. Molecular Formula:
    5. Molecular Weight: 476.613
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 769957-04-2.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: HDS02-174(CAS DataBase Reference)
    10. NIST Chemistry Reference: HDS02-174(769957-04-2)
    11. EPA Substance Registry System: HDS02-174(769957-04-2)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 769957-04-2(Hazardous Substances Data)

769957-04-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 769957-04-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,6,9,9,5 and 7 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 769957-04:
(8*7)+(7*6)+(6*9)+(5*9)+(4*5)+(3*7)+(2*0)+(1*4)=242
242 % 10 = 2
So 769957-04-2 is a valid CAS Registry Number.

769957-04-2Downstream Products

769957-04-2Relevant articles and documents

Novel and potent 17β-hydroxysteroid dehydrogenase type 1 inhibitors

Lawrence, Harshani R.,Vicker, Nigel,Allan, Gillian M.,Smith, Andrew,Mahon, Mary F.,Tutill, Helena J.,Purohit, Atul,Reed, Michael J.,Potter, Barry V. L.

, p. 2759 - 2762 (2005)

Structure-based drug design using the crystal structure of human 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) led to the discovery of novel, selective, and the most potent inhibitors of 17β-HSD1 reported to date. Compounds 1 and 2 contain a side cha

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 769957-04-2